@article{RECOVERY_Collaborative_Group-2022_91401,
title = {Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis},
author = {RECOVERY Collaborative Group},
month = {jul},
year = {2022},
abstract = {We aimed to evaluate the use of baricitinib, a Janus kinase (JAK) 1–2 inhibitor, for the treatment of patients admitted to hospital with COVID-19.},
pages = {359-368},
volume = {400},
issue = {10349},
journal = {The Lancet},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S0140-6736(22)01109-6},
}
